My blog’s Stem Cell Person of the Year Award process has gotten off to a very exciting start. I have an amazing bunch of nominees and about 1000 votes were case in about 12 hours. Based on some discussions with people yesterday, I believe a few clarifications are needed about the process: The award is …
Some important rules for Stem Cell Person of the Year Award: please read carefully Read More »
Here on The Niche I’m giving out a Stem Cell Person of the Year Award for 2012 along with all my other annual awards (e.g. best stem cell journal, paper, blog, comic, activist, etc). 2020 update: you can see future winners of the award here. The Person of the Year winner will get recognition for …
Stem Cell Person of the Year Finalists: time to vote Read More »
Every year I give out a number of awards (See 2010 and 2011 awards here). I usually do them all in one post, but this year I’m doing them mostly in separate posts. This is the first post for 2012 awards and this is for Stem Cell Journal of the Year 2012. Some brief background is in order. Last …
Stem cell journal of the year 2012: Cell Stem Cell Read More »
Often on this blog I focus on challenges or problems in the stem cell universe, but sometimes it is important to focus on the good news and 2012 had much of that. There are more stem cell-based clinical trials than ever before and there is good reason to believe that many FDA-approved stem cell products …
So far in my series of eight simple reasons not to get an unlicensed stem cell treatment I’ve covered three compelling reasons: potential loss of insurance coverage for negative outcomes that could cost hundreds of thousands of dollars, failure of patient follow up by the doctors and clinics, and exclusion from future clinical trial participation. …
Advanced Cell Technology (ACT) is well into clinical trials for macular degeneration (the leading cause of blindness) using human embryonic stem cell (hESC)-based retinal pigmented epithelial cells (RPE). To date, the trials suggest the products are safe. Efficacy? We don’t know. I am cautiously hopeful, but it is frustrating to know that most clinical trials …
Every now and then a paper on stem cells lands many international headlines and also captures people’s imaginations. This seems to be the case for the recent urine stem cell paper from a team in China, which has made huge headlines. In addition to mainstream media, the paper was covered in Wired here and also by one …
Why did urine stem cell paper create global media sensation? Read More »
I’ve received such a huge response (more than 20 nominees) for the Knoepfler Lab Stem Cell Person of the Year Award and the nominees to date are so awesome that I’ve decided for practical purposes to end the nomination period a bit earlier than originally planned. Thus, tomorrow Dec. 13 will be the last day …
The University of California (UC), a truly wonderful organization, seems to have made a misstep with its new logo. Below on the left is the old logo and on the right is the new logo. I did a poll here that got a huge response on what people thought the new symbol represented. Just 2% …
Have I got a stem cell for you! We hear a lot about the dangers of an increasing number of rogue stem cell clinics, but another critical trend has flown more under the radar: direct marketing of stem cells to doctors. This is big business and arguably one of the biggest threats to patients. In …